(E)-N-(6-morpholinobenzo[d]thiazol-2-yl)-2-(2-hydroxy-4-(4-methylbenzyloxy)benzylidene)hydrazinecarboxamide

ID: ALA3357970

PubChem CID: 137007044

Max Phase: Preclinical

Molecular Formula: C27H27N5O4S

Molecular Weight: 517.61

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(COc2ccc(/C=N/NC(=O)Nc3nc4ccc(N5CCOCC5)cc4s3)c(O)c2)cc1

Standard InChI:  InChI=1S/C27H27N5O4S/c1-18-2-4-19(5-3-18)17-36-22-8-6-20(24(33)15-22)16-28-31-26(34)30-27-29-23-9-7-21(14-25(23)37-27)32-10-12-35-13-11-32/h2-9,14-16,33H,10-13,17H2,1H3,(H2,29,30,31,34)/b28-16+

Standard InChI Key:  VKAHONSLUMSLBE-LQKURTRISA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
    6.9435  -11.1578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6402  -10.7398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9540  -11.9778    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3744  -11.9511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6694  -12.3745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3557  -11.1364    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4405   -6.0294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7878   -9.5869    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2618   -9.6442    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2697  -10.9764    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.2205   -6.7446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9710   -9.5918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7759  -11.1329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5585   -8.8880    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0615   -4.6046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4861  -10.7242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5669  -10.3004    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1825   -7.4683    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9992   -7.4605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6584   -5.3171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0664   -9.9050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8436   -5.3203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7501  -10.3054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0501   -3.1907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4128   -8.1648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7741   -9.4965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3995   -6.7521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6332   -7.4493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6479   -3.9004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8269   -3.9091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0652  -10.7241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4275   -4.6179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0087   -8.8734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6237   -6.0354    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2291   -8.1613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1919   -8.8783    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4812   -9.9014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  4  1  0
  5  4  1  0
  1  3  1  0
  2  1  1  0
  6  2  1  0
  3  5  1  0
 30 32  2  0
 23 17  1  0
 36 33  2  0
 19 18  1  0
 34  7  1  0
 13 16  2  0
 17 12  1  0
 12  8  1  0
 29 24  1  0
  7 22  1  0
 23  9  2  0
 21 31  2  0
 11 34  1  0
 12 14  2  0
 16 10  1  0
 15 29  2  0
 20 15  1  0
  9 37  1  0
 28 11  2  0
 31 13  1  0
  8 36  1  0
 22 20  2  0
 26 21  1  0
 37 16  1  0
 10 23  1  0
 35 28  1  0
 19 25  1  0
 33 25  1  0
 25 35  2  0
 32 22  1  0
 29 30  1  0
 11 27  1  0
 37 26  2  0
 27 19  2  0
 31  6  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3357970

    ---

Associated Targets(Human)

NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-N-SH (1499 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 517.61Molecular Weight (Monoisotopic): 517.1784AlogP: 4.88#Rotatable Bonds: 7
Polar Surface Area: 108.31Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.42CX Basic pKa: 0.89CX LogP: 5.51CX LogD: 5.22
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.24Np Likeness Score: -1.92

References

1. Ma J, Chen D, Lu K, Wang L, Han X, Zhao Y, Gong P..  (2014)  Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.,  86  [PMID:25171780] [10.1016/j.ejmech.2014.08.058]

Source